Park Square Financial Group, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Park Square Financial Group, LLC
- $145 Billion
- Q4 2024
A detailed history of Park Square Financial Group, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Park Square Financial Group, LLC holds 1,379 shares of CPRX stock, worth $31,565. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,379Holding current value
$31,565% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
348Shares Held
98.5MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$428 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$193 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$133 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$71.7 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$69 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.35B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...